ClinConnect ClinConnect Logo
Search / Trial NCT06207006

E-intervention on Subclinical Fear of Cancer Recurrence

Launched by THE UNIVERSITY OF HONG KONG · Jan 12, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new online program designed to help cancer survivors manage their fears about cancer coming back. It's called eConquerFear-HK, and it’s based on a method that helps people think about their worries in a healthier way. The trial is specifically looking at how well this program works for Chinese cancer survivors who are feeling anxious about their cancer returning, but who don’t have severe anxiety.

To participate, you need to be a Cantonese- or Mandarin-speaking survivor of colorectal or breast cancer who has recently completed surgery and any follow-up treatments, like chemotherapy or radiotherapy, within the last six months. Participants should also have mild to moderate fears about cancer recurrence, as measured by a questionnaire. If you join the trial, you can expect to use the online program and provide feedback on your experience. It’s a great opportunity to receive support and help others while contributing to valuable research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cantonese- or Mandarin-speaking Chinese cancer survivors
  • recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
  • had recently completed surgery as primary treatment
  • have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months
  • scored 13 to 21 on the fear of cancer recurrence-short form will be recruited.
  • Exclusion Criteria:
  • non-Chinese ethnicity
  • metastatic cancer
  • with current diagnosis of depression or psychosis or are currently receiving psychological treatments
  • language or intellectual difficulties that prevent them from understanding the intervention content
  • having limited or no Internet access.

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Danielle Ng, PhD

Principal Investigator

School of Public Health, The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported